Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis, DMARD-naive and Early Disease Patients”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT00596206
What this trial is testing

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Sanofi 124
Post-approval studies (Phase 4)UnknownNCT03813771
What this trial is testing

Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification

Who this might be right for
Rheumatoid Arthritis
University of Leeds 106
Testing effectiveness (Phase 2)Study completedNCT03163966
What this trial is testing

The EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
Rottapharm Biotech 248

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation